Hospitalized Patients With Severe Coronavirus Disease 2019 During the Omicron Wave in Israel: Benefits of a Fourth Vaccine Dose | Zendy

Tal BroshNissimov | Zendy; Khetam Hussein | Zendy; Yonit WienerWell | Zendy; Efrat OrenbuchHarroch | Zendy; Meital Elbaz | Zendy; Shelly LipmanArens | Zendy; ‪Yasmin Maor‬‏ | Zendy; Yael Yagel | Zendy; Bibiana Chazan | Zendy; Mirit Hershman-Sarafov | Zendy; Galia Rahav | Zendy; Oren Zimhony | Zendy; Adi Zaidman Shimshovitz | Zendy; Michal Chowers | Zendy

Open Access

Hospitalized Patients With Severe Coronavirus Disease 2019 During the Omicron Wave in Israel: Benefits of a Fourth Vaccine Dose

Author(s) -

Tal BroshNissimov,

Khetam Hussein,

Yonit WienerWell,

Efrat OrenbuchHarroch,

Meital Elbaz,

Shelly LipmanArens,

‪Yasmin Maor‬‏,

Yael Yagel,

Bibiana Chazan,

Mirit Hershman-Sarafov,

Galia Rahav,

Oren Zimhony,

Adi Zaidman Shimshovitz,

Michal Chowers

Publication year - 2022

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciac501

Subject(s) - medicine , odds ratio , confidence interval , incidence (geometry) , mechanical ventilation , vaccination , pneumonia , cohort , logistic regression , pediatrics , immunology , physics , optics

Waning immunity and an increased incidence of coronavirus disease 2019 (COVID-19) during the Omicron outbreak led the Israeli Ministry of Health to recommend a fourth vaccine dose for high-risk individuals. In this study, we assessed its effect for hospitalized patients with severe breakthrough COVID-19.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research